معرفی
Prof David Harrison is a Professor at the University of St Andrews' School of Medicine, affiliated with the Sir James Mackenzie Institute for Early Diagnosis and the Cellular Medicine Division. His research focuses on oncology, pharmacology, molecular biology, and AI-driven medical diagnostics. Key projects include the NuCana Biomed research agreement and the ICECAP initiative investigating immunopathology in severe COVID-19 cases. He supervises multiple PhD students and has contributed to advancements in drug development, cancer biology, and AI applications in pathology. His work spans clinical trials (e.g., RAMPART, NUC-3373 studies) and innovative imaging techniques (e.g., DESI-MSI for cancer metabolomics).
- Education: PhD (not explicitly stated in texts, inferred from academic rank).
Research Interests: Prof Harrison’s expertise includes cancer drug mechanisms, molecular enzymology (e.g., 4-oxo-L-proline reductase), AI-driven pathology automation (e.g., cervical biopsy analysis), and immunological responses in critical illnesses. His lab develops tools for high-resolution histopathological imaging and explores metabolic-phenotypic links in tumors.
Publications: Recent work includes studies on enzyme catalysis, clinical trial adaptations, and AI applications in diagnostics. These highlight his interdisciplinary approach to bridging basic science with translational medicine.
Awards: None explicitly listed in the provided texts.
Grants & Advising: Leads projects funded by NuCana Biomed (£171k) and Medical Research Scotland (£8k). Supervises eight PhD students focusing on drug mechanisms, imaging, and molecular biology.
Labs/Teams: Collaborates within the Sir James Mackenzie Institute and cellular medicine teams, contributing to multidisciplinary research in early diagnosis and treatment strategies.
